Hanns Lochmüller is awarded prestigious Tier 1 Canada Research Chair in neuromuscular genomics and health

We are thrilled to announce that Hanns has been awarded a Canada Research Chair (CRC) in Neuromuscular Genomics and Health. The announcement was made at a ceremony at the University of Victoria at noon today. The prestigious Tier 1 CRC awards are for outstanding researchers acknowledged by their peers as world leaders in their fields. The program aims to help chairholders achieve research excellence, improve Canada’s depth of knowledge and quality of life, strengthen the country’s international competitiveness, and train the next generation of highly skilled researchers through student supervision, teaching, and research coordination. In the same announcement CHEO Professor Kym Boycott was awarded a Tier 1 CRC in Rare Disease Precision Health.

Hanns said: “This CRC award is part of what enabled my move from Europe to Canada, and together with our recently awarded CIHR Project grant allows us to establish a really exciting research program in neuromuscular genomics and health here at the CHEO Research Institute in close partnership with the Department of Medicine of The Ottawa Hospital and the Brain and Mind Research Institute of Ottawa University. I’m delighted that Kym Boycott, a long-term friend and collaborator, has also received a Tier 1 chair at the same time: this is a clear demonstration of the strategic importance of rare disease research here in Ottawa and our leadership role will benefit not only Canadian patients but also many others around the world.”

Hanns with research associate and lab manager Sally Spendiff

Find out more

CHEO Research Institute press release

Government of Canada press release

Canada Research Chair program details

Hanns-crc

Read next...

Lochmüller Lab members gather for a group photo at the Ottawa NMD poster session.

Lochmüller Lab at Ottawa NMD 2023

This September 7th to 9th the University of Ottawa Éric Poulin Centre for Neuromuscular Disease (CNMD) hosted the 6th Ottawa International Conference on Neuromuscular Disease...
Figure from CMS study showing frequency of CMS-causing genes.

New Publication: Clinical and genetic characterisation of a large Indian congenital myasthenic syndrome cohort

Lochmüller Lab study identifying and genetically characterising the largest-ever Indian cohort of congenital myasthenic syndrome patients published in BRAIN: a journal of neurology. Congenital myasthenic syndromes...
The ProdGNE consortium posing in front of building.

Europe comes to Canada as Lochmüller Lab hosts the annual meeting of the ProDGNE consortium

This August we welcomed our international colleagues of the ProDGNE consortium to Ottawa as we hosted the annual meeting of ProDGNE, the three-year transnational pre-clinical...
K_OCONNOR_model_pic

New Publication: Bi-allelic variants of FILIP1 cause congenital myopathy, dysmorphism and neurological defects

Lochmüller Lab study on novel disease gene published in BRAIN: a journal of neurology. Filamin-A-interacting protein 1 (FILIP1) is a structural protein that is involved...
xr:d:DAFmd0iKQEo:9,j:7891826583529976397,t:23062115

NMD4C Receives Network Grant from CIHR-IMHA and Funding from MDC

We are excited to share that The Neuromuscular Disease Network for Canada (NMD4C) has received a network grant from the Canadian Institutes of Health Research...
Congratulations to the four funding award recipients!

Four Research Lab Members Receive Funding Awards

We are excited to share that four of our research team members have received competitive funding awards to support their projects. Academic awards for individual...